Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban

BACKGROUND: Direct oral anticoagulants (DOAC) including edoxaban are increasingly used for stroke prevention in atrial fibrillation. Despite treatment, annual stroke rate in these patients remains 1–2%. Rapid assessment of coagulation would be useful to guide thrombolysis or reversal therapy in this...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neurol Res Pract
Prif Awduron: Härtig, Florian, Birschmann, Ingvild, Peter, Andreas, Hörber, Sebastian, Ebner, Matthias, Sonnleitner, Matthias, Spencer, Charlotte, Bombach, Paula, Stefanou, Maria-Ioanna, Tünnerhoff, Johannes, Mengel, Annerose, Kuhn, Joachim, Ziemann, Ulf, Poli, Sven
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2021
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7919064/
https://ncbi.nlm.nih.gov/pubmed/33641678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s42466-021-00105-4
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg